SKI Market

Indian Indices

Nifty

24,967.75 97.65
(0.39%)

Sensex

80,786.54 -849.37
( -1.04%)

Bank Nifty

55,139.30 -10.10
( -0.02%)

Nifty IT

36,280.10 839.25
( 2.37%)

Global Indices

Nasdaq

45,305.71 -347.04
(-0.76%)

Dow Jones

6,460.93 -26.98
(-0.42%)

Hang Seng

42,449.84 -357.98
(-0.84%)

Nikkei 225

9,321.40 12.20
(0.13%)

Forex

USD-INR

87.34 0.17
(0.20%)

EUR-INR

102.37 0.98
(0.96%)

GBP-INR

118.09 0.93
(0.80%)

JPY-INR

0.59 0.00
(0.82%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Rudra Global Infra Products Ltd

Industry : Steel - Medium / Small

BSE Code

ISIN Demat

Book Value()

539226

INE027T01023

12.4623424

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

26.52

306.05

EPS(TTM)

Face Value()

Div & Yield %

1.15

Back

Glenmark Pharmaceuticals consolidated net profit declines 86.23% in the June 2025 quarter

Aug 15,2025

Net profit of Glenmark Pharmaceuticals declined 86.23% to Rs 46.87 crore in the quarter ended June 2025 as against Rs 340.27 crore during the previous quarter ended June 2024. Sales declined 5.09% to Rs 3059.33 crore in the quarter ended June 2025 as against Rs 3223.30 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	3059.33	3223.30	-5
OPM %	18.98	18.25	-
PBDT	548.73	580.12	-5
PBT	418.81	462.33	-9
NP	46.87	340.27	-86

24,967.75 97.65 (0.39%)

80,786.54 -849.37 ( -1.04%)

55,139.30 -10.10 ( -0.02%)

36,280.10 839.25 ( 2.37%)

45,305.71 -347.04 (-0.76%)

6,460.93 -26.98 (-0.42%)

42,449.84 -357.98 (-0.84%)

9,321.40 12.20 (0.13%)

87.34 0.17 (0.20%)

102.37 0.98 (0.96%)

118.09 0.93 (0.80%)

0.59 0.00 (0.82%)